Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).

E Frasch, Carl; Preziosi, Marie-Pierre; Marc LaForce, F

doi:10.4161/hv.19619

Public

Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).

Shared by NobleBlocks on Jun 1, 2012 • 12:00 AM UTC

Authors:

Carl E Frasch

Marie-Pierre Preziosi

F Marc LaForce

Abstract

Group A meningococcal disease has been an important public health problem in sub-Saharan Africa for over a century. Outbreaks occur there annually, and large epidemics occur at intervals ranging between 8 and 12 y. The Meningitis Vaccine Project was established in 2001 with funding from the Gates Fo...

Discussions